Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Christine H. Chung, Barbara A. Murphy, Nancy J. Muldowney et al.|Annals of Oncology|2009

Cited by 62